Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 5161 AL 5175

Verbal episodic memory profiles in HIV-Associated Neurocognitive Disorders (HAND): A comparison with Huntington's disease and mesial temporal lobe epilepsy

Doyle KL, Woods SP, McDonald CR, Leyden KM, Holden HM, E Morgan E, Gilbert PE, Corey-Bloom J.

Appl Neuropsychol Adult. 2019 Jan-Feb;26(1):17-27. doi: 10.1080/23279095.2017.1353993. Epub 2017 Aug 29.

Design optimization for clinical trials in early-stage manifest Huntington's disease

Frost C, Mulick A, Scahill RI, Owen G, Aylward E, Leavitt BR, Durr A, Roos RAC, Borowsky B, Stout JC, Reilmann R, Langbehn DR, Tabrizi SJ, Sampaio C; TRACK-HD Investigators.

Mov Disord. 2017 Nov;32(11):1610-1619. doi: 10.1002/mds.27122. Epub 2017 Sep 14.

Medical management of motor manifestations of Huntington disease

McCusker EA, Loy CT.

Handb Clin Neurol. 2017;144:141-150. doi: 10.1016/B978-0-12-801893-4.00012-2.

The role of rehabilitation therapy in Huntington disease

Quinn L, Busse M.

Handb Clin Neurol. 2017;144:151-165. doi: 10.1016/B978-0-12-801893-4.00013-4.

Preclinical motor manifestations of Huntington disease

McGarry A, Biglan KM.

Handb Clin Neurol. 2017;144:93-98. doi: 10.1016/B978-0-12-801893-4.00007-9.

The Neuropsychology of Huntington's Disease

Snowden JS.

Arch Clin Neuropsychol. 2017 Nov 1;32(7):876-887. doi: 10.1093/arclin/acx086.

Unilateral Thalamic Infarct Presenting as a Convulsive Seizure

Kumar R, Brohi H, Mughul A.

J Coll Physicians Surg Pak. 2017 Sep;27(9):S104-S105.

Editorial: Pathophysiology of the Basal Ganglia and Movement Disorders: Gaining New Insights from Modeling and Experimentation, to Influence the Clinic

Andres DS, Merello M, Darbin O.

Front Hum Neurosci. 2017 Sep 20;11:466. doi: 10.3389/fnhum.2017.00466. eCollection 2017.

[Neuropsychiatry Of Movement Disorders]

Orjuela-Rojas JM, Barrios Vincos GA, Martínez Gallego MA.

Rev Colomb Psiquiatr. 2017 Oct;46 Suppl 1:59-68. doi: 10.1016/j.rcp.2017.05.010. Epub 2017 Jun 20.

[Movement disorders: An update]

Béreau M, Tranchant C.

Rev Med Interne. 2018 Aug;39(8):641-649. doi: 10.1016/j.revmed.2017.09.001. Epub 2017 Oct 16.

Anaesthesia and orphan disease: airway and anaesthetic management in Huntington's disease

Nguyen PT, Meeks D, Liotiri D.

BMJ Case Rep. 2017 Oct 19;2017:bcr2017221354. doi: 10.1136/bcr-2017-221354.

A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders

Lim K, See YM, Lee J.

Clin Psychopharmacol Neurosci. 2017 Nov 30;15(4):301-312. doi: 10.9758/cpn.2017.15.4.301.

Restorative Strategies in Movement Disorders: the Contribution of Imaging

Lao-Kaim NP, Piccini P, Tai YF.

Curr Neurol Neurosci Rep. 2017 Nov 2;17(12):98. doi: 10.1007/s11910-017-0807-1.

Autoantibody-Associated Movement Disorders in Children: Proven and Proposed

Singer HS.

Semin Pediatr Neurol. 2017 Aug;24(3):168-179. doi: 10.1016/j.spen.2017.08.003. Epub 2017 Aug 14.

The Movement Disorder of Brain-Lung-Thyroid Syndrome Can be Responsive to Methylphenidate

Gauquelin L, Tran LT, Chouinard S, Bernard G.

Tremor Other Hyperkinet Mov (N Y). 2017 Oct 26;7:508. doi: 10.7916/D84X5M9Z. eCollection 2017.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias